Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 38,602 shares at $12.70 ($490K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($490k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.70 | 19,301 | $245K | 50.0% |
| 2 | $12.70 | 19,301 | $245K | 50.0% |
| Total | $12.70 avg | 38,602 | $490K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2024-12-23 | $228K | — | Filing → |